These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T. Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260 [Abstract] [Full Text] [Related]
14. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury. Kuyvenhoven JP, Molenaar IQ, Verspaget HW, Veldman MG, Palareti G, Legnani C, Moolenburgh SE, Terpstra OT, Lamers CB, van Hoek B, Porte RJ. Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226 [Abstract] [Full Text] [Related]
15. Protease activities, as well as plasminogen activators, contribute to the "lytic" state during orthotopic liver transplantation. Legnani C, Palareti G, Rodorigo G, Gozzetti G, Mazziotti A, Martinelli G, Zanello M, Sama C, Coccheri S. Transplantation; 1993 Sep; 56(3):568-72. PubMed ID: 7692627 [Abstract] [Full Text] [Related]
16. Changes in the contact system during orthotopic liver transplantation with and without aprotinin. Segal HC, Hunt BJ, Cottam S, Beard C, Francis JL, Potter D, Tan KC. Transplantation; 1995 Feb 15; 59(3):366-70. PubMed ID: 7532878 [Abstract] [Full Text] [Related]
17. Regular alcohol intake and fibrinolysis. van Golde PM, Hart HCh, Kraaijenhagen RJ, Bouma BN, van de Wiel A. Neth J Med; 2002 Aug 15; 60(7):285-8. PubMed ID: 12430575 [Abstract] [Full Text] [Related]
20. Activation of the fibrinolytic system in patients with coronary artery disease and hyperfibrinogenemia. Stein D, Heins M, Schoebel FC, Pels K, Jax TW, Stiegler H, Reinauer H, Strauer BE, Leschke M. Thromb Haemost; 1997 May 15; 77(5):970-4. PubMed ID: 9184412 [Abstract] [Full Text] [Related] Page: [Next] [New Search]